BOCA RATON, Fla., Feb. 09, 2026 (GLOBE NEWSWIRE) -- ADT Inc. (NYSE: ADT) today announced its inclusion into the S&P SmallCap 600® Index, effective prior to the opening of trading this morning, Feb. 9, ...

ADT has been treading water for the past six months, recording a small loss of 2.3% while holding steady at $8.24. The stock also fell short of the S&P 500’s 10% gain during that period. Is now the ...

Nonlinear improvement seen in relative benefit of distant metastasis, OS, with reduced benefits beyond 9 to 12 months of ADT. HealthDay News — Increasing duration of androgen deprivation therapy (ADT) ...

Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.

ATLANTA — ADT can chalk up another legal victory, this one in Georgia. Commercial subscriber Robert Webb entered a building in Georgia to turn off a false alarm and was exposed to an alarm, which it ...

I’ve been working with computers for ages, starting with a multi-year stint in purchasing for a major IBM reseller in New York City before eventually landing at PCMag (back when it was still in print ...

Sept 1 (Reuters) - French carmaker Renault (RENA.PA), opens new tab appointed former Mercedes-Benz (MBGn.DE), opens new tab vice president Katrin Adt as managing director of its low-cost Dacia brand, ...

ADT’s Nest-integrated security system is one of my favorite parts of my smart home, in part because it has a lot of futuristic ideas. Recently, ADT added a new smart lock option to its lineup, and the ...

ADT reduces testosterone, crucial for prostate cancer cell growth, but causes side effects impacting quality of life. Cardiovascular risks, insulin resistance, and bone density loss are significant ...

ADT (ADT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.16 per share a year ago. These figures are ...

ADT’s Chief Marketing and Communications Officer DeLu Jackson keynoted the annual CTV Connect Conference earlier this month, presented by Chief Marketer Network publications Cynopsis, AdExchanger, ...

The addition of a short-course of ADT to metastasis-directed therapy delays progression in patients with oligometastatic hormone-sensitive prostate cancer. Adding 6 months of androgen deprivation ...